Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Phreesia (PHR) Research & Development (2018 - 2026)

Phreesia's Research & Development history spans 9 years, with the latest figure at $30.9 million for Q1 2026.

  • On a quarterly basis, Research & Development rose 4.38% to $30.9 million in Q1 2026 year-over-year; TTM through Jan 2026 was $121.5 million, a 3.51% increase, with the full-year FY2026 number at $121.5 million, up 3.51% from a year prior.
  • Research & Development hit $30.9 million in Q1 2026 for Phreesia, up from $29.5 million in the prior quarter.
  • Over the last five years, Research & Development for PHR hit a ceiling of $31.8 million in Q2 2025 and a floor of $17.5 million in Q1 2022.
  • Historically, Research & Development has averaged $27.1 million across 5 years, with a median of $28.9 million in 2024.
  • Biggest five-year swings in Research & Development: surged 175.3% in 2022 and later fell 0.91% in 2025.
  • Tracing PHR's Research & Development over 5 years: stood at $22.7 million in 2022, then increased by 25.92% to $28.5 million in 2023, then rose by 2.7% to $29.3 million in 2024, then rose by 0.47% to $29.5 million in 2025, then rose by 5.0% to $30.9 million in 2026.
  • Business Quant data shows Research & Development for PHR at $30.9 million in Q1 2026, $29.5 million in Q4 2025, and $29.3 million in Q3 2025.